does eli lilly have a patent on tirzepatide Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval As Novo's patent expires, GLP-1

Both Tirzepatide and Semaglutide are injectable GLP-1 medications used for medical weight loss, but there are important differences between them: Clinical data consistently shows that Tirzepatide produces greater average weight loss than Semaglutide due to its dual hormone action

The caloric deficit created by appetite suppression does not selectively burn fat

Individual results may vary, and no guarantees of specific outcomes are made

This includes the elderly and those with neurological issues

Hypoglycemia warning: Do not use RETATRUTIDE if you have a history of recurrent or severe hypoglycemia

Keshavarz-Bahaghighat H, Sepand MR, Ghahremani MH, et al